Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
China flag China · Delayed Price · Currency is CNY
6.22
+0.09 (1.47%)
Nov 6, 2026, 11:55 AM CST

SHE:002872 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-53.85-55.42-87.4-93.07-90.56-67.81
Depreciation & Amortization
120.55120.55108.64107.26107.7289.99
Other Amortization
6.16.14.252.832.763.25
Loss (Gain) From Sale of Assets
0.160.16-0.04-0.23-9.53-5.22
Asset Writedown & Restructuring Costs
0.180.1824.184.813.218.48
Loss (Gain) From Sale of Investments
-6.25-6.25-16.56-2.01-4.92-4.57
Provision & Write-off of Bad Debts
2.972.97-0.784.241.2717.58
Other Operating Activities
64.7534.5343.8629.4531.8810.6
Change in Accounts Receivable
16.4116.4115.65103.0354.68-419.09
Change in Inventory
-0.02-0.0228.0349.47-6.86167.57
Change in Accounts Payable
-71.33-71.33-61.96-231.1-4.71187.8
Change in Other Net Operating Assets
--2.092.16--
Operating Cash Flow
74.7642.9750.15-24.5689.1818.97
Operating Cash Flow Growth
53.48%-14.31%--370.09%-90.00%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-35.23-26.92-50.27-76.74-73.42-114.38
Sale of Property, Plant & Equipment
4.365.820.0915.0514.8836.34
Cash Acquisitions
----30--29.4
Divestitures
----22.4531.08
Investment in Securities
-0.88-1.3130-82-72.7
Other Investing Activities
6.395.9925.75156.66.12318.64
Investing Cash Flow
-25.36-16.415.57-82.08-65.57169.58

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-159.3282.5213.3101226.74
Long-Term Debt Repaid
--157.11-221.85-208.97-167.53-358.33
Lease Payments
-1.33-1.33-1.56-3.4-2.61-2.61
Net Debt Issued (Repaid)
-36.372.1960.654.33-66.53-131.59
Common Dividends Paid
-14.25-14.97-15.26-15.54-15.94-22.89
Other Financing Activities
0.83-5.16-3815.51
Financing Cash Flow
-49.8-12.7950.56-11.2-44.47-138.97

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
-0.413.77106.27-117.85-20.8549.58

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
39.5416.05-0.13-101.315.76-95.41
Free Cash Flow Growth
23.79%-----
Free Cash Flow Margin
7.79%3.12%-0.02%-17.49%2.60%-12.95%
Free Cash Flow Per Share
0.120.05--0.320.05-0.30
Levered Free Cash Flow
73.0776.9357.93-57.8-37.29171.75
Unlevered Free Cash Flow
73.0783.9667.17-48.43-27.43186.97
Free Cash Flow After Leases
38.214.72-1.68-104.713.15-98.02

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
58.6945.9248.5160.4922.1924.21
Change in Working Capital
-59.85-59.85-26-77.8447.35-33.34